Legal & General Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388M | Sell |
|
|||||
|
2025
Q1 | $474M | Sell |
|
|||||
|
2024
Q4 | $554M | Sell |
|
|||||
|
2024
Q3 | $825M | Buy |
|
|||||
|
2024
Q2 | $824M | Sell |
|
|||||
|
2024
Q1 | $789M | Sell |
|
|||||
|
2023
Q4 | $726M | Buy |
|
|||||
|
2023
Q3 | $675M | Sell |
|
|||||
|
2023
Q2 | $609M | Sell |
|
|||||
|
2023
Q1 | $698M | Buy |
|
|||||
|
2022
Q4 | $600M | Sell |
|
|||||
|
2022
Q3 | $601M | Sell |
|
|||||
|
2022
Q2 | $522M | Buy |
|
|||||
|
2022
Q1 | $564M | Buy |
|
|||||
|
2021
Q4 | $474M | Sell |
|
|||||
|
2021
Q3 | $464M | Buy |
|
|||||
|
2021
Q2 | $416M | Buy |
|
|||||
|
2021
Q1 | $335M | Sell |
|
|||||
|
2020
Q4 | $349M | Buy |
|
|||||
|
2020
Q3 | $382M | Sell |
|
|||||
|
2020
Q2 | $432M | Buy |
|
|||||
|
2020
Q1 | $261M | Buy |
|
|||||
|
2019
Q4 | $196M | Buy |
|
|||||
|
2019
Q3 | $139M | Buy |
|
|||||
|
2019
Q2 | $155M | Buy |
|
|||||
|
2019
Q1 | $196M | Buy |
|
|||||
|
2018
Q4 | $144M | Buy |
|
|||||
|
2018
Q3 | $145M | Buy |
|
|||||
|
2018
Q2 | $121M | Sell |
|
|||||
|
2018
Q1 | $126M | Buy |
|
|||||
|
2017
Q4 | $136M | Sell |
|
|||||
|
2017
Q3 | $166M | Buy |
|
|||||
|
2017
Q2 | $181M | Buy |
|
|||||
|
2017
Q1 | $140M | Buy |
|
|||||
|
2016
Q4 | $126M | Buy |
|
|||||
|
2016
Q3 | $137M | Buy |
|
|||||
|
2016
Q2 | $118M | Buy |
|
|||||
|
2016
Q1 | $121M | Sell |
|
|||||
|
2015
Q4 | $186M | Buy |
|
|||||
|
2015
Q3 | $147M | Buy |
|
|||||
|
2015
Q2 | $156M | Buy |
|
|||||
|
2015
Q1 | $137M | Sell |
|
|||||
|
2014
Q4 | $124M | Sell |
|
|||||
|
2014
Q3 | $110M | Sell |
|
|||||
|
2014
Q2 | $90.8M | Buy |
|
|||||
|
2014
Q1 | $95.6M | Buy |
|
|||||
|
2013
Q4 | $86.3M | Buy |
|
|||||
|
2013
Q3 | $97.4M | Buy |
|
|||||
|
2013
Q2 | $66.9M | Buy |
|